Clearbridge Investments, LLC Argenx Se Transaction History

Clearbridge Investments, LLC

$119 Billion
Q4 2024

A detailed history of Clearbridge Investments, LLC transactions in Argenx Se stock. As of the latest transaction made, Clearbridge Investments, LLC holds 629,828 shares of ARGX stock, worth $403 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

629,828

Previous 589,498 6.84%

Holding current value

$403 Million

Previous $320 Million 21.16%

% of portfolio

0.33%

Previous 0.26%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$520.52 - $638.33 $21 Million - $25.7 Million	40,330 Added 6.84%	629,828 $387 Million
Q3 2024 Nov 12, 2024	SELL	$434.22 - $551.9 $12.1 Million - $15.4 Million	-27,968 Reduced 4.53%	589,498 $320 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $7.54 Million - $9.57 Million	21,189 Added 3.55%	617,466 $266 Million
Q1 2024 May 13, 2024	BUY	$356.95 - $413.29 $56.9 Million - $65.9 Million	159,480 Added 36.51%	596,277 $235 Million
Q4 2023 Feb 09, 2024	BUY	$338.91 - $506.01 $31.3 Million - $46.8 Million	92,433 Added 26.84%	436,797 $166 Million
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $64.6 Million - $95.9 Million	174,894 Added 103.2%	344,364 $169 Million
Q2 2023 Aug 11, 2023	BUY	$360.14 - $422.58 $13.3 Million - $15.6 Million	36,826 Added 27.76%	169,470 $66 Million
Q1 2023 May 12, 2023	SELL	$334.23 - $403.65 $3.19 Million - $3.85 Million	-9,545 Reduced 6.71%	132,644 $49.4 Million
Q4 2022 Feb 10, 2023	SELL	$342.17 - $402.31 $7.3 Million - $8.58 Million	-21,330 Reduced 13.04%	142,189 $53.9 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $537,794 - $620,140	-1,567 Reduced 0.95%	163,519 $57.7 Million
Q2 2022 Aug 11, 2022	SELL	$269.58 - $378.88 $16 Million - $22.5 Million	-59,418 Reduced 26.47%	165,086 $62.5 Million
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $134,604 - $185,710	529 Added 0.24%	224,504 $70.8 Million
Q4 2021 Feb 11, 2022	SELL	$272.01 - $353.03 $16.2 Million - $21 Million	-59,412 Reduced 20.96%	223,975 $78.4 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $10.5 Million - $12.5 Million	35,688 Added 14.41%	283,387 $85.6 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $15.6 Million - $19.4 Million	60,519 Added 32.33%	247,699 $74.6 Million
Q1 2021 May 13, 2021	BUY	$268.3 - $380.31 $50.2 Million - $71.2 Million	187,180 New	187,180 $51.5 Million

Others Institutions Holding ARGX

# of Institutions

431

Shares Held

29.2M

Call Options Held

390K

Put Options Held

272K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.4B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Argenx Se Transaction History